Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis

Background: The incidence rate and mortality of bladder cancer are increasing year by year. Interestingly, the commonly used metabolic regulatory drug metformin has been reported to have anti-tumor effect in recent years. Nevertheless, it keeps unclear whether the usage of metformin is beneficial or...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen-Qian, Sun, Jian-Xuan, Xu, Jin-Zhou, Qian, Xiao-Yuan, Hong, Sen-Yuan, Xu, Meng-Yao, An, Ye, Xia, Qi-Dong, Hu, Jia, Wang, Shao-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021395/
https://www.ncbi.nlm.nih.gov/pubmed/35462910
http://dx.doi.org/10.3389/fphar.2022.865988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021395/
https://www.ncbi.nlm.nih.gov/pubmed/35462910
http://dx.doi.org/10.3389/fphar.2022.865988

Ejemplares similares